Performance of pharmaceutical companies in India a critical analysis of industrial structure, firm specific resources, and emerging strategies /

This book explains how government support and institutional set up facilitated the evolution of the Indian pharmaceutical industry and provides an economic analysis of firm strategies due to recent policy changes. The book is useful for researchers interested in understanding the transition of a lif...

Full description

Main Author: Mazumdar, Mainak.
Other Authors: SpringerLink (Online service)
Format: eBook
Language: English
Published: New York : Physica-Verlag, ©2013.
New York : [2013]
Physical Description: 1 online resource (xviii, 202 pages) : illustrations.
Series: Contributions to economics.
Subjects:
LEADER 04684cam a2200769Ma 4500
001 820852066
003 OCoLC
005 20240223121953.0
006 m o d
007 cr cn|||||||||
008 121107s2013 nyua ob 001 0 eng d
019 |a 988807021  |a 1121470765  |a 1229833246 
020 |a 9783790828764  |q (e-book) 
020 |a 3790828769 
020 |a 9783790828764 
020 |a 3790828750  |q (print) 
020 |a 9783790828757  |q (print) 
020 |z 9783790828757 
024 7 |a 10.1007/978-3-7908-2876-4  |2 doi 
035 |a (OCoLC)820852066  |z (OCoLC)988807021  |z (OCoLC)1121470765  |z (OCoLC)1229833246 
040 |a E7B  |b eng  |e pn  |c E7B  |d OCLCO  |d OCLCQ  |d OCLCF  |d NOC  |d VT2  |d OCLCO  |d UX0  |d COO  |d YDXCP  |d OCLCQ  |d UAB  |d Z5A  |d ESU  |d OCLCQ  |d IOG  |d REB  |d OCLCA  |d U3W  |d OL$  |d OCLCQ  |d STF  |d LVT  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
043 |a a-ii--- 
049 |a COM6 
050 4 |a HD9672.I42  |b M39 2013eb 
082 0 4 |a 330  |2 23 
100 1 |a Mazumdar, Mainak. 
245 1 0 |a Performance of pharmaceutical companies in India :  |b a critical analysis of industrial structure, firm specific resources, and emerging strategies /  |c Mainak Mazumdar. 
260 |a New York :  |b Physica-Verlag,  |c ©2013. 
264 1 |a New York :  |b Physica-Verlag,  |c [2013] 
264 4 |c ©2013. 
300 |a 1 online resource (xviii, 202 pages) :  |b illustrations. 
336 |a text  |b txt  |2 rdacontent. 
337 |a computer  |b c  |2 rdamedia. 
338 |a online resource  |b cr  |2 rdacarrier. 
490 1 |a Contributions to economics,  |x 1431-1993. 
504 |a Includes bibliographical references and index. 
505 0 |a An Overview of the Pharmaceutical Sector in India -- The sources of Heterogenity in the Efficiency of Indian Pharmaceutical Firms -- Comparing Efficiency Across Various Groups of Firms: A Meta-Frontier Approach -- Examining the Efficiency, Technical, and Productivity Changes of the Indian Pharmaceutical Firms: A Malmquist-Meta Frontier Approach -- Profitability of the Indian Pharmaceutical Firms -- The Problem of Availability of Patented Drugs due to Product Patent and Parallel Trade: A Theoretical Approach -- Conclusions and Policy Implications. 
520 |a This book explains how government support and institutional set up facilitated the evolution of the Indian pharmaceutical industry and provides an economic analysis of firm strategies due to recent policy changes. The book is useful for researchers interested in understanding the transition of a lifeline sector for an emerging economy like India. Students of public policy, health administrators and health economists who are interested in the functioning of the pharmaceutical sector that produces life saving drugs in developing nations will find this book useful. The book also provides good coverage on data envelopment analysis (DEA), a useful technique for understanding productivity and efficiency. It can provide guidance to the research students on the applicability of DEA technique to address various research questions for analysis. The book will be a valuable addition to libraries in colleges of pharmacy and medicine as well as to all other academic and research centers. 
650 0 |a Pharmaceutical industry  |z India. 
650 6 |a Industrie pharmaceutique  |z Inde. 
650 7 |a Pharmaceutical industry.  |2 fast. 
651 7 |a India.  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJmdx47cDXrRhBXHtbvPwC. 
710 2 |a SpringerLink (Online service) 
776 0 8 |i Printed edition:  |z 9783790828757. 
830 0 |a Contributions to economics. 
907 |a .b46372787  |b multi  |c -  |d 150401  |e 240320 
998 |a (3)cue  |a cu  |b 240227  |c m  |d z   |e -  |f eng  |g nyu  |h 0  |i 2 
948 |a MARCIVE Overnight, in 2024.03 
948 |a MARCIVE Comp, in 2022.12 
948 |a MARCIVE Over, 07/2021 
948 |a MARCIVE Comp, 2018.05 
948 |a MARCIVE August, 2017 
948 |a MARCIVE Aug 5, 2017 
994 |a 92  |b COM 
995 |a Loaded with m2btab.ltiac in 2024.03 
995 |a Loaded with m2btab.elec in 2024.02 
995 |a Loaded with m2btab.ltiac in 2022.12 
995 |a Loaded with m2btab.ltiac in 2021.07 
995 |a Loaded with m2btab.elec in 2021.06 
995 |a Loaded with m2btab.ltiac in 2018.06 
995 |a Loaded with m2btab.ltiac in 2017.08 
995 |a Loaded with m2btab.elec in 2016 
995 |a Loaded with m2btab.elec in 2016 
995 |a OCLC offline update by CMU 
999 |e z 
999 |a cue 
989 |d cueme  |e  - -   |f  - -   |g -   |h 0  |i 0  |j 200  |k 240227  |l $0.00  |m    |n  - -   |o -  |p 0  |q 0  |t 0  |x 0  |w SpringerLink  |1 .i150330327  |u http://ezproxy.coloradomesa.edu/login?url=https://link.springer.com/10.1007/978-3-7908-2876-4  |3 SpringerLink  |z Click here for access